Bulletin
Investor Alert

Intellia Therapeutics Inc.

NAS: NTLA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 3, 2023, 7:54 p.m.

/zigman2/quotes/207821052/composite

$

44.78

Change

+1.55 +3.59%

Volume

Volume 13,888

Quotes are delayed by 20 min

/zigman2/quotes/207821052/composite

Previous close

$ 44.60

$ 43.23

Change

-1.37 -3.07%

Day low

Day high

$42.42

$44.51

Open

52 week low

52 week high

$32.44

$104.87

Open

Insider Actions for Intellia Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/05/2023 Laura Sepp-Lorenzino
EVP, Chief Scientific Officer
689   Disposition at $39.1 per share. 26,939
01/05/2023 Laura Sepp-Lorenzino
EVP, Chief Scientific Officer
1,641   Disposition at $38.22 per share. 62,719
01/04/2023 John M. Leonard
President and CEO; Director
6,673   Disposition at $37.21 per share. 248,302
01/04/2023 David Lebwohl
EVP, Chief Medical Officer
2,574   Disposition at $37.21 per share. 95,778
01/04/2023 James Basta
EVP, General Counsel
1,138   Disposition at $37.21 per share. 42,344
01/04/2023 Laura Sepp-Lorenzino
EVP, Chief Scientific Officer
2,508   Disposition at $37.21 per share. 93,322
01/04/2023 Derek Hicks
EVP, Chief Business Officer
1,812   Disposition at $37.21 per share. 67,424
01/04/2023 Glenn Goddard
EVP, Chief Financial Officer
2,427   Disposition at $37.21 per share. 90,308
01/04/2023 Eliana Clark
EVP, Chief Technical Officer
1,692   Disposition at $37.21 per share. 62,959
01/03/2023 Eliana Clark
EVP, Chief Technical Officer
231   Disposition at $34.48 per share. 7,964
01/01/2023 John M. Leonard
President and CEO; Director
7,848   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2023 David Lebwohl
EVP, Chief Medical Officer
3,187   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2023 Laura Sepp-Lorenzino
EVP, Chief Scientific Officer
3,500   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2023 Glenn Goddard
EVP, Chief Financial Officer
3,062   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2022 Eliana Clark
EVP, Chief Technical Officer
105   Disposition at $51.74 per share. 5,432
06/14/2022 Fred Ehrenkranz Cohen
Director
5,197   Award at $0 per share. 0
06/14/2022 Caroline D. Dorsa
Director
5,197   Award at $0 per share. 0
06/14/2022 Georgia Keresty
Director
5,197   Award at $0 per share. 0
06/14/2022 Muna Bhanji
Director
2,014   Award at $0 per share. 0
06/14/2022 John Francis Crowley
Director
5,197   Award at $0 per share. 0
06/14/2022 Jean-Francois B. Formela
Director
5,197   Award at $0 per share. 0
06/14/2022 Frank A. G. M. Verwiel
Director
5,197   Award at $0 per share. 0
06/14/2022 Jesse L. Goodman
Director
5,197   Award at $0 per share. 0
04/28/2022 Muna Bhanji
Director
7,954   Award at $0 per share. 0
03/01/2022 John M. Leonard
President and CEO; Director
40,990   Award at $0 per share. 0
03/01/2022 David Lebwohl
EVP, Chief Medical Officer
13,816   Award at $0 per share. 0
03/01/2022 Glenn Goddard
EVP, Chief Financial Officer
12,720   Award at $0 per share. 0
03/01/2022 Eliana Clark
EVP, Chief Technical Officer
10,527   Award at $0 per share. 0
01/03/2022 Derek Hicks
EVP, Chief Business Officer
19,118   Award at $0 per share. 0
01/01/2022 John M. Leonard
President and CEO; Director
2,493   Disposition at $112.26 per share. 279,864
01/01/2022 David Lebwohl
EVP, Chief Medical Officer
1,051   Disposition at $112.24 per share. 117,964
01/01/2022 Glenn Goddard
EVP, Chief Financial Officer
1,013   Disposition at $112.24 per share. 113,699
01/01/2022 John M. Leonard
President and CEO; Director
7,848   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2022 David Lebwohl
EVP, Chief Medical Officer
3,187   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2022 Glenn Goddard
EVP, Chief Financial Officer
3,062   Derivative/Non-derivative trans. at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
4 Purchases
10 Sales
17,597
21,385
Last 6 months
4 Purchases
10 Sales
17,597
21,385
Last 12 months
17 Purchases
11 Sales
141,997
21,490

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Treasurer, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Chief Technology Officer & Executive VP
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Mr. Derek Hicks
Chief Business Officer & Executive Vice President
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Frank A. G. M. Verwiel
Chairman
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Ms. Muna Bhanji
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse L. Goodman
Independent Director
Dr. Fred Ehrenkranz Cohen
Independent Director
Link to MarketWatch's Slice.